Pirozyński M, Szymańska D, Targosz L, Cieślicki J, Meleniewska-Maciszewska A, Załeska J
Instytutu Gruźlicy i Chorób Płuc w Warszawie.
Pneumonol Alergol Pol. 1991;59(5-6):187-92.
The aim of the study was to assess the diagnostic effectiveness and safety of "blind" transbronchial lung biopsy (B-TBLB) in interstitial lung diseases (ILD). The diagnostic yield of B-TBLB performed in 44 patients was compared with similar yield of classical TBLB carried out in 25 patients. A diagnosis was made by B-TBLB in 29 patients (65.9%) and 14 (56%) by classical TBLB. Most often sarcoidosis, allergic alveolitis, pneumoconioses were found. Side effects were seen in both groups: in the B-TBLB group in 11.4%, in patients that underwent classical TBLB in 32%. It seems that blind transbronchial lung biopsy is a safe, effective and acceptable diagnostical method of interstitial lung disorders.
本研究旨在评估“盲法”经支气管肺活检(B-TBLB)在间质性肺疾病(ILD)中的诊断有效性及安全性。将44例患者接受B-TBLB的诊断阳性率与25例患者接受传统TBLB的类似阳性率进行比较。B-TBLB诊断出29例患者(65.9%),传统TBLB诊断出14例患者(56%)。最常发现的疾病是结节病、过敏性肺泡炎和尘肺。两组均出现了副作用:B-TBLB组为11.4%,接受传统TBLB的患者为32%。盲法经支气管肺活检似乎是一种安全、有效且可接受的间质性肺疾病诊断方法。